LAROSA JOSEPH J 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
- Tax Payment
Common Stock
2024-12-16$730.81/sh−702$513,029→ 30,075 total
Holdings
- 371(indirect: By 401(k))
Common Stock
- 9,000(indirect: By 2024 GRAT)
Common Stock